← Back to signals
ICLR
AVOIDICON plc
Health Care
1.88
PEGY ratio
Rank #347
Why This Matters
This stock appears overvalued relative to its growth and dividend yield. Strong projected growth of 305.8% annually over 5 years.
ICLR trades at 46.9x earnings against 25.0% capped growth (actual 305.8%) (no dividend) (PEGY 1.88). The valuation appears stretched relative to the available growth and income.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 305.8%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-05-29
Valuation
46.9x
P/E Ratio
Growth
305.8%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score1.88
Denominator25.0%
EPS (TTM)$2.90
Market Data
Price$136.07
ExchangeNASDAQ
S&P 500
What Changed
PEGY Score
0.63→1.88(+1.25)
Zone
Strong Buy→Avoid
Rank
#71→#347(276 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only